Literature DB >> 387872

Experimental malaria in the CBA/N mouse.

A N Jayawardena, C A Janeway, J D Kemp.   

Abstract

CBA/N mice carry an X-linked, recessive gene, which results in the absence of a B cell subset, and is expressed primarily as an inability to respond to a certain class of thymus-independent antigens. We have examined the responses of these mice to the malaria parasite Plasmodium yoelii and found that primary infections induced by this parasite are more severe and last longer in mice with X-linked defect than in normal controls. The decreased resistance of the defective mice is associated with a striking deficiency in their IgM antibody response. After recovery from a primary infection, defective mice resist reinfection with the homologous parasite as well as normal mice. Although as resistant as normal controls, B cells from defective mice transfer considerably less immunity to naive recipients than B cells from normal animals. Hence, two modes of thymus-dependent protective immunity may contribute to the host response to P. yoelii. Control of an acute primary infection appears to involve a thymus-dependent antibody response that CBA/N mice are deficient in. Resistance to reinfection may be mediated primarily by a different mechanism.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 387872

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  A role for rheumatoid factor enhancement of Plasmodium falciparum schizont inhibition in vitro.

Authors:  T J Green; B J Packer
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

2.  Acquired resistance to Giardia muris in X-linked immunodeficient mice.

Authors:  D L Skea; B J Underdown
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

3.  Augmentation of protective and antibacterial activity induced by muramyl dipeptides in CBA/N defective mice with X-linked immunodeficiency for Salmonella enteritidis infection.

Authors:  K Onozuka; T Saito-Taki; M Nakano
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

4.  Susceptibility of CXB recombinant inbred mice to murine plasmodia.

Authors:  E J Hoffmann; W P Weidanz; C A Long
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem S Abdel-Baki; Marcos J Araúzo-Bravo; Denis Delic; Frank Wunderlich
Journal:  Parasitol Res       Date:  2014-07-24       Impact factor: 2.289

6.  Plasmodium berghei malaria: effects of acute-phase serum and erythrocyte-bound immunoglobulins on erythrophagocytosis by rat peritoneal macrophages.

Authors:  B J Packer; J P Kreier
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso.

Authors:  C Boudin; B Chumpitazi; M Dziegiel; F Peyron; S Picot; B Hogh; P Ambroise-Thomas
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Murine malaria: genetic control of resistance to Plasmodium chabaudi.

Authors:  M M Stevenson; J J Lyanga; E Skamene
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

9.  CD4+ and CD8+ T lymphocytes both contribute to acquired immunity to blood-stage Plasmodium chabaudi AS.

Authors:  J E Podoba; M M Stevenson
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

10.  T-cell-mediated immune response in murine malaria: differential effects of antigen-specific Lyt T-cell subsets in recovery from Plasmodium yoelii infection in normal and T-cell-deficient mice.

Authors:  V Brinkmann; S H Kaufmann; M M Simon
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.